Cc1cc([N+](=O)[O-])ccc1NC(=O)CN1C2CCC1CC(NC(=O)NC13CC4CC(CC(C4)C1)C3)C2
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?